Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
Nature Communications
|
December 9, 2020
The biosecurity benefits of genetic engineering attribution
Gregory Lewis, Jacob L Jordan, David A Relman, et al.
Cancer Research
|
September 18, 2004
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity
John A Hartley, Victoria J Spanswick, Natalie Brooks, et al.
Stress (Amsterdam, Netherlands)
|
December 2, 2024
California Stress, Trauma, and Resilience Study (CalSTARS) protocol: A multiomics-based cross-sectional investigation and randomized controlled trial to elucidate the biology of ACEs and test a precision intervention for reducing stress and enhancing resilience
Lauren Y Kim, Sophia Miryam Schüssler-Fiorenza Rose, Summer Mengelkoch, et al.
Bioanalysis
|
December 3, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 - hybrid LBA/LCMS and input from regulatory agencies)
Brad Ackermann, Hendrik Neubert, Nicola Hughes, et al.
Injury
|
October 4, 2021
Proximal tibia fracture dislocations: Management and outcomes of a severe and under-recognized injury
Lukas G Keil, Brian H Mullis, Paul Tornetta Iii, et al.
Bioanalysis
|
December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)
Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Bioanalysis
|
November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity)
Hendrik Neubert, Timothy Olah, Anita Lee, et al.
Bioanalysis
|
November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)
Jan Welink, Eric Yang, Nicola Hughes, et al.
Bioanalysis
|
December 23, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input)
Dawn Dufield, Hendrik Neubert, Fabio Garofolo, et al.
Bioanalysis
|
January 20, 2021
2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome (<u>Part 1</u> - Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos)
Hendrik Neubert, Stephen C Alley, Anita Lee, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
Nature Communications
|
December 9, 2020
The biosecurity benefits of genetic engineering attribution
Gregory Lewis, Jacob L Jordan, David A Relman, et al.
Cancer Research
|
September 18, 2004
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity
John A Hartley, Victoria J Spanswick, Natalie Brooks, et al.
Stress (Amsterdam, Netherlands)
|
December 2, 2024
California Stress, Trauma, and Resilience Study (CalSTARS) protocol: A multiomics-based cross-sectional investigation and randomized controlled trial to elucidate the biology of ACEs and test a precision intervention for reducing stress and enhancing resilience
Lauren Y Kim, Sophia Miryam Schüssler-Fiorenza Rose, Summer Mengelkoch, et al.
Bioanalysis
|
December 3, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 - hybrid LBA/LCMS and input from regulatory agencies)
Brad Ackermann, Hendrik Neubert, Nicola Hughes, et al.
Injury
|
October 4, 2021
Proximal tibia fracture dislocations: Management and outcomes of a severe and under-recognized injury
Lukas G Keil, Brian H Mullis, Paul Tornetta Iii, et al.
Bioanalysis
|
December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)
Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Bioanalysis
|
November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity)
Hendrik Neubert, Timothy Olah, Anita Lee, et al.
Bioanalysis
|
November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)
Jan Welink, Eric Yang, Nicola Hughes, et al.
Bioanalysis
|
December 23, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input)
Dawn Dufield, Hendrik Neubert, Fabio Garofolo, et al.
Bioanalysis
|
January 20, 2021
2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome (<u>Part 1</u> - Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos)
Hendrik Neubert, Stephen C Alley, Anita Lee, et al.
Page
of 14